Champix Reviews - Champix Coupons Discount Rates Australia

, FL (PressExposure) April 07, 2009 -- Champix is a new generation of smoking treatment, supplementing the company Pfizer. It is prescription medication that can help even the majority of smokers are dependent on the habit. Available through After an online consultation, Champix is currently the best anti-smoking drug on the market. Buy Champix Online UK for the treatment of smoking cessation.

Champix contains the active ingredient varenicline tartrate, a nicotinic receptor antagonist. Varenicline submit to the receptors in the brain, usually of nicotine and thus fool the brain into thinking that he had with a dose of nicotine. This satisfies the urge for a cigarette, without the brain actually fed nicotine. In other words, it satisfies the craving for a cigarette, without a.

Champix was first in the U.S. and Chantix has now been approved and the UK as Champix. Champix has proved very effective in all studies, has been through - the main reason that it takes to start smoking and the rewarding effect of nicotine on the brain is exercised.

The actions of nicotine is its ability to increase production of dopamine in the body. Champix works in the same way by increasing the amount of dopamine through the body. This helps reduce the craving for smoking.

Champix has a decisive advantage over Zyban - the other major anti-smoking drug is currently available on the market. This advantage has been demonstrated beyond doubt in clinical studies as well. Studies have found Champix has a 44% success rate compared to only 29.5% for Zyban.

The reason for Champix is so effective is the action. It directly blocks the receptors that nicotine uses to get to the brain and control. Zyban on the other hand, is originally an anti-depressant medication. It was found, with smoking cessation only by chance and later approved as such. But not the same anti-smoking effect, such as Champix.

About Champix Virtuale

For more information about Champix reviews, Champix Australia visit []

Press Release Source:

Press Release Submitted On: April 06, 2009 at 2:21 am
This article has been viewed 3707 time(s).